logo

For the Inventor, By the Inventor

Chippenham, United Kingdom

Vectura Gmbh

Calculating rank
USPTO Granted Patents = 71

% Expired Patents = 43.7



Trademarks = 4

Forward Citations = 754

Loading Chart...
Loading Chart...

58 inventors (with patents filed for the assignee):

goldMedal John Nicholas Staniforth (33 out of 83 patents)

silverMedal David Alexander Vodden Morton (23 out of 25 patents)

bronzeMedal Matthew Green (8 out of 8 patents)

4.  Martin Huber (8 out of 10 patents)

5.  Tobias Kolb (8 out of 18 patents)

6.  Rossella Musa (6 out of 17 patents)

7.  David Morton (5 out of 5 patents)

8.  Stephen William Eason (5 out of 30 patents)

9.  Haggis Harris (5 out of 5 patents)

10.  Robin Mark Bannister (5 out of 80 patents)

11.  Roger William Clarke (5 out of 60 patents)

12.  Fergus Paul Manford (4 out of 4 patents)

13.  Gaetano Brambilla (4 out of 28 patents)

14.  Kambiz Yadidi (4 out of 20 patents)

15.  Bernhard Muellinger (4 out of 9 patents)


Core Competencies:
Inhalation Device
Dry Powder Formulation
Aerosol Therapy
Micronized Particles
Pharmaceutical Compositions
Jet Milling Method
Carrier Particles
Respiratory Diseases
Pharmaceutical Inhaler
Formulations
Mucoactive Agents
Surface-Modified Particles

71 patents:

1. 12251506 - Mixing channel for an inhalation device and inhalation device (2025-03-18),
2. 12144820 - Dry powder formulations for inhalation (2024-11-19),
3. 11865210 - Dry powder formulations and methods of use (2024-01-09),
4. 11819569 - Treating inflammation with inhaled aspirin (2023-11-21),
5. 11759791 - Jet milling method (2023-09-19),
6. 11596603 - Dry powder formulations for inhalation (2023-03-07),
7. 11583587 - Polymer (2023-02-21),
8. 11229915 - Jet milling method (2022-01-25),
9. 11219602 - Method for making a micronized dry powder formulation of glycopyrrolate and magnesium stearate (2022-01-11),
10. 11103448 - Manufacture of pharmaceutical compositions (2021-08-31),
11. 10973771 - Method of making particles for use in a pharmaceutical composition (2021-04-13),
12. 10857310 - Mixing channel for an inhalation device and inhalation device (2020-12-08),
13. 10821116 - Administration of iloprost as aerosol bolus (2020-11-03),
14. 10729647 - Use of stearate in an inhalable formulation (2020-08-04),
15. 10682477 - Dosing system for an inhalation device (2020-06-16),
Company Overview
Vectura GmbH, headquartered in Chippenham, GB, specializes in the development and manufacturing of advanced inhalation devices aimed at treating respiratory diseases. The company focuses on innovative technologies such as dry powder formulations and aerosol therapy, utilizing micronized particles and carrier particles to enhance drug delivery. Vectura's expertise in jet milling methods positions it as a leader in the pharmaceutical sector, dedicated to improving patient outcomes through effective respiratory therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

71 Patents

#2 in Chippenham

#263 in United Kingdom

#10,532 in the World

Chippenham, GB
Chippenham, United Kingdom

Vectura Gmbh

Forward Citations = 754

58 inventors:

goldMedal John Nicholas Staniforth (33 out of 83 patents)

silverMedal David Alexander Vodden Morton (23 out of 25 patents)

bronzeMedal Matthew Green (8 out of 8 patents)

4.  Martin Huber (8 out of 10 patents)

5.  Tobias Kolb (8 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vectura Gmbh. Retrieved from https://idiyas.com/company/vectura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…